Engineering temperature-sensitive SH3 domains

Chemistry and Biology

Volumn 6, Issue 10, 1999, Pages 679-687

  Parrini, Maria Carla ^a   Mayer, Bruce J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Nck; SH2 SH3 adaptors; SH3 domain; Signal transduction; Temperature sensitive mutation

Indexed keywords

MUTAGENESIS; MUTATION; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN PROTEIN INTERACTION;

EID: 0033214071     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)80015-0     Document Type: Article

References (43)

1. 1. Michalovitz, D., Halevy, O. & Oren, M. (1990), Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62, 671-680.
2. 2. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. & Oren, M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347.
3. 3. Caelles, C., Helmberg, A. & Karin, M. (1994). p53-dependent apoptosis in the absence of transcriptional activation of p53 target genes. Nature 370, 220-223.
4. 4. Friedlander, P., Legros, Y., Soussi, T. & Prives, C. (1996). Regulation of mutant p53 temperature-sensitive DNA binding. J. Biol. Chem. 271, 25468-25478.
5. 5. Martin, G.S. (1970). Rous sarcoma virus: a function required for the maintenance of the transformed state. Nature 227, 1021-1023.
6. 6. Sefton, B.M., Hunter, T., Beemon, K. & Eckhart, W. (1980). Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 20, 807-816.
7. 7. Pawson, T. (1995). Protein modules and signalling networks. Nature 373, 573-580.
8. 8. Cohen, G.B., Ren, R. & Baltimore, D. (1995). Modular binding domains in signal transduction proteins. Cell 80, 237-248.
9. 9. Galisteo, M.L., Chernoff, J., Su, Y.C., Skolnik, E.Y. & Schlessinger, J. (1996). The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1. J. Biol. Chem. 271, 20997-21000.
10. 10. Bokoch, G.M., Wang, Y., Bohl, B.P., Sells, M.A, Quilliam, L.A. & Knaus, U.G. (1996). Interaction of the Nck adapter protein with p21 -activated kinase (PAK1). J. Biol. Chem. 271, 25746-25749.
11. 11. Lu, W., Katz, S., Gupta, R. & Mayer, B.J. (1997). Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr. Biol. 7, 85-94.
12. 12. Lehmann, J.M., Riethmuller, G. & Johnson, J.P. (1990). Nck, a melanoma cDNA encoding a cytoplasmic protein consisting of the Src homology units SH2 and SH3. Nucleic Acids Res. 18, 1048.
13. 13. Manser, E., Leung, T., Salihuddin, H., Zhao, Z.S. & Lim, L. (1994). A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40-46.
14. 14. Knaus, U.G., Morris, S., Dong, H.J., Chernoff, J. & Bokoch, G.M. (1995). Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269, 221-223.
15. 15. Martin, G.A., Bollag, G., McCormick, F. & Abo, A. (1995). A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J. 14, 4385.
16. 16. Manser, E., et al., & Lim, L. (1997). Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol. Cell. Biol. 17, 1129-1143.
17. 17. Sells, M.A., Knaus, U.G., Bagrodia, S., Ambrose, D.M., Bokoch, G.M. & Chernoff, J. (1997). Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7, 202-210.
18. 18. Frost, J.A., Khokhlatchev, A., Stippec, S., White, M.A. & Cobb, M.H. (1998). Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation. J. Biol. Chem. 273, 28191-28198.
19. 19. Zhao, Z.S., Manser, E., Chen, X.Q., Chong, C., Leung, T. & Lim, L. (1998). A conserved negative regulatory region in alphaPAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol. Cell Biol. 18, 2153-2163.
20. 20. Schlessinger, J. (1993). How receptor tyrosine kinases activate Ras. Trends Biochem. Sci. 18, 273-275.
21. 21. Mayer, B.J., Hamaguchi, M. & Hanafusa, H. (1988). A novel viral oncogene with structural similarity to phospholipase C. Nature 332, 272-275.
22. 22. Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T. & Shibuya, M. (1992). Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12, 3482-3489.
23. 23. Tanaka, M., Gupta, R. & Mayer, B.J. (1995). Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell. Biol. 15, 6829-6837.
24. 24. Musacchio, A., Saraste, M. & Wilmanns, M. (1994). High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat. Struct. Biol. 1, 546-551.
25. 25. Mayer, B.J. & Hanafusa, H. (1990). Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation. J. Virol. 64, 3581-3589.
26. 26. Sakai, R., et al., & Hirai, H. (1994). A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13, 3748-3756.
27. 27. Mayer, B. J., Hirai, H. & Sakai, R. (1995). Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5, 296-305.
28. 28. Ren, R., Ye, Z.S. & Baltimore, D. (1994). Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8, 783-795.
29. 29. Feller, S.M., Knudsen, B. & Hanafusa, H. (1994). c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13, 2341-2351.
30. 30. Alber, T., Sun, D.P., Nye, J.A., Muchmore, D.C. & Matthews, B.W. (1987). Temperature-sensitive mutations of bacteriophage T4 lysozyme occur at sites with low mobility and low solvent accessibility in the folded protein. Biochemistry 26, 3754-3758.
31. 31. Bokoch, G.M., et al., & Knaus, U.G. (1998). A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids. J. Biol. Chem. 273, 8137-8144.
32. 32. Lu, W. & Mayer, B.J. (1999). Mechanism of activation of Pak1 kinase by membrane localization. Oncogene 18, 797-806.
33. 33. Gossen, M. & Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA 89, 5547-5551.
34. 34. Sawyers, C.L., McLaughlin, J., Goga, A., Havlik, M. & Witte, O. (1994). The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77, 121-131.
35. 35. Jackson, P. & Baltimore, D. (1989). N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8, 449-456.
36. 36. Franz, W.M., Berger, P. & Wang, J.Y. (1989). Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8, 137-147.
37. 37. Grantcharova, V.P. & Baker, D. (1997). Folding dynamics of the src SH3 domain. Biochemistry 36, 15685-15692.
38. 38. Guijarro, J.I., Morton, C.J., Plaxco, K.W., Campbell, I.D. & Dobson, C.M. (1998). Folding kinetics of the SH3 domain of PI3 kinase by real-time NMR combined with optical spectroscopy. J. Mol. Biol. 276, 657-667.
39. 39. Plaxco, K.W., Guijarro, J.I., Morton, C.J., Pitkeathly, M., Campbell, I.D. & Dobson, C.M. (1998). The folding kinetics and thermodynamics of the Fyn-SH3 domain. Biochemistry 37, 2529-2537.
40. 40. Muhlrad, D., Hunter, R. & Parker, R. (1992). A rapid method for localized mutagenesis of yeast genes. Yeast 8, 79-82.
41. 41. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. & Pease, L.R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
42. 42. Morgenstern, J.P. & Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
43. 43. Glenney, J.R., Jr., Zokas, L. & Kamps, M.P. (1988). Monoclonal antibodies to phosphotyrosine. J. Immunol. Methods 109, 277-285.